Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 46

1.

Integrins and ERp57 Coordinate to Regulate Cell Surface Calreticulin in Immunogenic Cell Death.

Liu CC, Leclair P, Pedari F, Vieira H, Monajemi M, Sly LM, Reid GS, Lim CJ.

Front Oncol. 2019 May 28;9:411. doi: 10.3389/fonc.2019.00411. eCollection 2019.

2.

Tumor Variant Identification That Accounts for the Unique Molecular Landscape of Pediatric Malignancies.

Lorentzian A, Biegel JA, Ostrow DG, Rolf N, Liu CC, Rassekh SR, Deyell RJ, Triche T, Schultz KR, Rozmus J, Reid GSD, Lim CJ, Lange PF, Maxwell CA.

JNCI Cancer Spectr. 2018 Oct;2(4):pky079. doi: 10.1093/jncics/pky079. Epub 2019 Jan 25.

3.

TLR9 limits enteric antimicrobial responses and promotes microbiota-based colonisation resistance during Citrobacter rodentium infection.

Yang H, Yu HB, Bhinder G, Ryz NR, Lee J, Yang H, Fotovati A, Gibson DL, Turvey SE, Reid GS, Vallance BA.

Cell Microbiol. 2019 Jul;21(7):e13026. doi: 10.1111/cmi.13026. Epub 2019 May 7.

PMID:
30893495
4.

CD47-ligation induced cell death in T-acute lymphoblastic leukemia.

Leclair P, Liu CC, Monajemi M, Reid GS, Sly LM, Lim CJ.

Cell Death Dis. 2018 May 1;9(5):544. doi: 10.1038/s41419-018-0601-2.

5.

Combination therapy with proteasome inhibitors and TLR agonists enhances tumour cell death and IL-1β production.

Tang AC, Rahavi SM, Fung SY, Lu HY, Yang H, Lim CJ, Reid GS, Turvey SE.

Cell Death Dis. 2018 Feb 7;9(2):162. doi: 10.1038/s41419-017-0194-1.

6.

The non-motor adaptor HMMR dampens Eg5-mediated forces to preserve the kinetics and integrity of chromosome segregation.

Chen H, Connell M, Mei L, Reid GSD, Maxwell CA.

Mol Biol Cell. 2018 Jan 31. pii: mbc.E17-08-0531. doi: 10.1091/mbc.E17-08-0531. [Epub ahead of print]

7.

Generation of a multi-antigen-directed immune response for durable control of acute lymphoblastic leukemia.

Jo S, Lee JH, Mattei JJ, Barrett DM, van den Elzen P, Grupp SA, Reid GSD, Seif AE.

Leukemia. 2018 Feb;32(2):574. doi: 10.1038/leu.2017.312. Epub 2018 Jan 5.

PMID:
29303505
8.

Absolute lymphocyte counts at end of induction correlate with distinct immune cell compartments in pediatric B cell precursor acute lymphoblastic leukemia.

Rolf N, Smolen KK, Kariminia A, Velenosi A, Fidanza M, Strahlendorf C, Seif AE, Reid GSD.

Cancer Immunol Immunother. 2018 Feb;67(2):225-236. doi: 10.1007/s00262-017-2070-3. Epub 2017 Oct 20.

PMID:
29052781
9.

Cell Cycle-Dependent Tumor Engraftment and Migration Are Enabled by Aurora-A.

Chu TLH, Connell M, Zhou L, He Z, Won J, Chen H, Rahavi SMR, Mohan P, Nemirovsky O, Fotovati A, Pujana MA, Reid GSD, Nielsen TO, Pante N, Maxwell CA.

Mol Cancer Res. 2018 Jan;16(1):16-31. doi: 10.1158/1541-7786.MCR-17-0417. Epub 2017 Oct 9.

10.

Generation of a multi-antigen-directed immune response for durable control of acute lymphoblastic leukemia.

Jo S, Lee JH, Mattei JJ, Barrett DM, van den Elzen P, Grupp SA, Reid GSD, Seif AE.

Leukemia. 2018 Feb;32(2):539-542. doi: 10.1038/leu.2017.290. Epub 2017 Sep 19. No abstract available. Erratum in: Leukemia. 2018 Jan 05;:.

PMID:
28924244
11.

IFN-γ directly inhibits murine B-cell precursor leukemia-initiating cell proliferation early in life.

Fidanza M, Seif AE, Jo S, Kariminia A, Rolf N, Sly LM, Grupp SA, Reid GSD.

Eur J Immunol. 2017 May;47(5):892-899. doi: 10.1002/eji.201646806. Epub 2017 Apr 11.

12.

Y-box-binding protein 1 contributes to IL-7-mediated survival signaling in B-cell precursor acute lymphoblastic leukemia.

Kariminia A, Ivison SM, Leung VM, Sung S, Couto N, Rozmus J, Rolf N, Narendran A, Dunn SE, Reid GS, Schultz KR.

Oncol Lett. 2017 Jan;13(1):497-505. doi: 10.3892/ol.2016.5437. Epub 2016 Nov 28.

13.

α-Integrin expression and function modulates presentation of cell surface calreticulin.

Liu CC, Leclair P, Monajemi M, Sly LM, Reid GS, Lim CJ.

Cell Death Dis. 2016 Jun 16;7:e2268. doi: 10.1038/cddis.2016.176.

14.

Inhibition of precursor B-cell malignancy progression by toll-like receptor ligand-induced immune responses.

Fidanza M, Seif AE, DeMicco A, Rolf N, Jo S, Yin B, Li Y, Barrett DM, Duque-Afonso J, Cleary ML, Bassing CH, Grupp SA, Reid GS.

Leukemia. 2016 Oct;30(10):2116-2119. doi: 10.1038/leu.2016.152. Epub 2016 May 25. No abstract available.

15.

Intravenous immunoglobulin skews macrophages to an anti-inflammatory, IL-10-producing activation state.

Kozicky LK, Zhao ZY, Menzies SC, Fidanza M, Reid GS, Wilhelmsen K, Hellman J, Hotte N, Madsen KL, Sly LM.

J Leukoc Biol. 2015 Dec;98(6):983-94. doi: 10.1189/jlb.3VMA0315-078R. Epub 2015 Jul 27.

PMID:
26216934
16.

Heterodimer-specific TLR2 stimulation results in divergent functional outcomes in B-cell precursor acute lymphoblastic leukemia.

Rolf N, Kariminia A, Ivison S, Reid GS, Schultz KR.

Eur J Immunol. 2015 Jul;45(7):1980-90. doi: 10.1002/eji.201444874. Epub 2015 May 6.

17.

Family members' experience of seeking help for first-episode psychosis on behalf of a loved one: a meta-synthesis of qualitative research.

Cairns VA, Reid GS, Murray C.

Early Interv Psychiatry. 2015 Jun;9(3):185-99. doi: 10.1111/eip.12157. Epub 2014 Jun 23. Review.

PMID:
24958353
18.

The Queen and I: neural correlates of altered self-related cognitions in major depressive episode.

Sarsam M, Parkes LM, Roberts N, Reid GS, Kinderman P.

PLoS One. 2013 Oct 30;8(10):e78844. doi: 10.1371/journal.pone.0078844. eCollection 2013.

19.

Informal caregivers in early psychosis: evaluation of need for psychosocial intervention and unresolved grief.

Mulligan J, Sellwood W, Reid GS, Riddell S, Andy N.

Early Interv Psychiatry. 2013 Aug;7(3):291-9. doi: 10.1111/j.1751-7893.2012.00369.x. Epub 2012 Jun 28.

PMID:
22741743
20.

Noninvasive bioluminescent imaging of primary patient acute lymphoblastic leukemia: a strategy for preclinical modeling.

Barrett DM, Seif AE, Carpenito C, Teachey DT, Fish JD, June CH, Grupp SA, Reid GS.

Blood. 2011 Oct 13;118(15):e112-7. doi: 10.1182/blood-2011-04-346528. Epub 2011 Aug 19.

21.

Interferon-gamma-dependent infiltration of human T cells into neuroblastoma tumors in vivo.

Reid GS, Shan X, Coughlin CM, Lassoued W, Pawel BR, Wexler LH, Thiele CJ, Tsokos M, Pinkus JL, Pinkus GS, Grupp SA, Vonderheide RH.

Clin Cancer Res. 2009 Nov 1;15(21):6602-8. doi: 10.1158/1078-0432.CCR-09-0829. Epub 2009 Oct 13.

22.

Long-term protection from syngeneic acute lymphoblastic leukemia by CpG ODN-mediated stimulation of innate and adaptive immune responses.

Seif AE, Barrett DM, Milone M, Brown VI, Grupp SA, Reid GS.

Blood. 2009 Sep 17;114(12):2459-66. doi: 10.1182/blood-2009-02-203984. Epub 2009 Jul 27.

23.

Novel molecular and cellular therapeutic targets in acute lymphoblastic leukemia and lymphoproliferative disease.

Brown VI, Seif AE, Reid GS, Teachey DT, Grupp SA.

Immunol Res. 2008;42(1-3):84-105. doi: 10.1007/s12026-008-8038-9. Review.

24.

mTOR inhibitors are synergistic with methotrexate: an effective combination to treat acute lymphoblastic leukemia.

Teachey DT, Sheen C, Hall J, Ryan T, Brown VI, Fish J, Reid GS, Seif AE, Norris R, Chang YJ, Carroll M, Grupp SA.

Blood. 2008 Sep 1;112(5):2020-3. doi: 10.1182/blood-2008-02-137141. Epub 2008 Jun 10.

25.

Detection of WT1-specific T cells in paediatric acute lymphoblastic leukaemia patients in first remission.

Barbaric D, Corthals SL, Jastaniah WA, Asalanian S, Shimizu H, Reid GS, Schultz KR.

Br J Haematol. 2008 Apr;141(2):271-3. doi: 10.1111/j.1365-2141.2008.07001.x. Epub 2008 Feb 26. No abstract available.

PMID:
18307567
26.

Targeting Notch signaling in autoimmune and lymphoproliferative disease.

Teachey DT, Seif AE, Brown VI, Bruno M, Bunte RM, Chang YJ, Choi JK, Fish JD, Hall J, Reid GS, Ryan T, Sheen C, Zweidler-McKay P, Grupp SA.

Blood. 2008 Jan 15;111(2):705-14. Epub 2007 Oct 9.

27.

Altered Toll-like receptor 9 responses in circulating B cells at the onset of extensive chronic graft-versus-host disease.

She K, Gilman AL, Aslanian S, Shimizu H, Krailo M, Chen Z, Reid GS, Wall D, Goldman F, Schultz KR.

Biol Blood Marrow Transplant. 2007 Apr;13(4):386-97. Epub 2007 Feb 15.

28.

In vivo control of acute lymphoblastic leukemia by immunostimulatory CpG oligonucleotides.

Fujii H, Trudeau JD, Teachey DT, Fish JD, Grupp SA, Schultz KR, Reid GS.

Blood. 2007 Mar 1;109(5):2008-13. Epub 2006 Oct 26.

PMID:
17068155
29.

Differential immune effects mediated by Toll-like receptors stimulation in precursor B-cell acute lymphoblastic leukaemia.

Corthals SL, Wynne K, She K, Shimizu H, Curman D, Garbutt K, Reid GS.

Br J Haematol. 2006 Feb;132(4):452-8.

PMID:
16412017
30.

HLA-DM expression is elevated in ETV6-AML1 translocation-positive pediatric acute lymphoblastic leukemia.

Jastaniah WA, Alessandri AJ, Reid GS, Schultz KR.

Leuk Res. 2006 Apr;30(4):487-9. Epub 2005 Sep 26.

PMID:
16191436
31.
32.
33.

Progression of spontaneous autoimmune diabetes is associated with a switch in the killing mechanism used by autoreactive CTL.

Qin H, Trudeau JD, Reid GS, Lee IF, Dutz JP, Santamaria P, Verchere CB, Tan R.

Int Immunol. 2004 Nov;16(11):1657-62. Epub 2004 Oct 5.

PMID:
15466911
34.

Primary immunodeficiency to pneumococcal infection due to a defect in Toll-like receptor signaling.

Currie AJ, Davidson DJ, Reid GS, Bharya S, MacDonald KL, Devon RS, Speert DP.

J Pediatr. 2004 Apr;144(4):512-8.

PMID:
15069402
35.

The cationic antimicrobial peptide LL-37 modulates dendritic cell differentiation and dendritic cell-induced T cell polarization.

Davidson DJ, Currie AJ, Reid GS, Bowdish DM, MacDonald KL, Ma RC, Hancock RE, Speert DP.

J Immunol. 2004 Jan 15;172(2):1146-56. Erratum in: J Immunol. 2004 Feb 15;172(4):following 2703.

36.

Altered patterns of T cell cytokine production induced by relapsed pre-B ALL cells.

Reid GS, Terrett L, Alessandri AJ, Grubb S, Stork L, Seibel N, Gaynon P, Schultz KR.

Leuk Res. 2003 Dec;27(12):1135-42.

PMID:
12921952
37.

Imagery and psychotic symptoms: a preliminary investigation.

Morrison AP, Beck AT, Glentworth D, Dunn H, Reid GS, Larkin W, Williams S.

Behav Res Ther. 2002 Sep;40(9):1053-62.

PMID:
12296490
38.

Differential killing of pre-B acute lymphoblastic leukaemia cells by activated NK cells and the NK-92 ci cell line.

Reid GS, Bharya S, Klingemann HG, Schultz KR.

Clin Exp Immunol. 2002 Aug;129(2):265-71.

39.

ETV6 (TEL)-AML1 pre-B acute lymphoblastic leukaemia cells are associated with a distinct antigen-presenting phenotype.

Alessandri AJ, Reid GS, Bader SA, Massing BG, Sorensen PH, Schultz KR.

Br J Haematol. 2002 Feb;116(2):266-72.

PMID:
11841426
40.
41.
42.

Costs and benefits of cervical screening. III. Cost/benefit analysis of a call of previously unscreened women.

Waugh N, Smith I, Robertson A, Reid GS, Halkerston R, Grant A.

Cytopathology. 1996 Aug;7(4):249-55.

PMID:
8853971
43.

Costs and benefits of cervical screening. I. The costs of the cervical screening programme.

Waugh N, Smith I, Robertson A, Reid GS, Halkerston R, Grant A.

Cytopathology. 1996 Aug;7(4):231-40.

PMID:
8853969
44.

Cervical screening in Perth and Kinross since introduction of the new contract.

Reid GS, Robertson AJ, Bissett C, Smith J, Waugh N, Halkerston R.

BMJ. 1991 Aug 24;303(6800):447-50.

45.

How complete can cervical screening be? The outcome of a call screening programme for women aged 20-60 years in Perth and Kinross.

Robertson AJ, Reid GS, Stoker CA, Bissett C, Waugh N, Fenton I, Rowan J, Halkerston R.

Cytopathology. 1990;1(1):3-12.

PMID:
2130997
46.

Evaluation of a call programme for cervical cytology screening in women aged 50-60.

Robertson AJ, Reid GS, Stoker CA, Bissett C, Waugh N, Fenton I, Rowan J, Halkerston R.

BMJ. 1989 Jul 15;299(6692):163-6.

Supplemental Content

Support Center